The global market for Coagulation Factor IX was estimated to be worth US$ 362 million in 2023 and is forecast to a readjusted size of US$ 526 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030

Coagulation Factor IX - Market

Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coagulation Factor IX, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Coagulation Factor IX by region & country, by Type, and by Application.

The Coagulation Factor IX market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factor IX.

Market Segmentation

Scope of Coagulation Factor IX - Market Report

Report Metric	Details
Report Name	Coagulation Factor IX - Market
Forecasted market size in 2030	US$ 526 million
CAGR	5.8%
Forecasted years	2024 - 2030
Segment by Type:	Coagulation Factor IX (Plasma Derived) Coagulation Factor IX (Recombinant)
Segment by Application	Adult Kids
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, CSL Behring, Grifols, Novo Nordisk, Bioverativ, Sanquin, Takeda, Baxter, Aptevo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Coagulation Factor IX in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Coagulation Factor IX in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Coagulation Factor IX - Market size in 2030?

Ans: The Coagulation Factor IX - Market size in 2030 will be US$ 526 million.

Who are the main players in the Coagulation Factor IX - Market report?

Ans: The main players in the Coagulation Factor IX - Market are Pfizer, CSL Behring, Grifols, Novo Nordisk, Bioverativ, Sanquin, Takeda, Baxter, Aptevo

What are the Application segmentation covered in the Coagulation Factor IX - Market report?

Ans: The Applications covered in the Coagulation Factor IX - Market report are Adult, Kids

What are the Type segmentation covered in the Coagulation Factor IX - Market report?

Ans: The Types covered in the Coagulation Factor IX - Market report are Coagulation Factor IX (Plasma Derived), Coagulation Factor IX (Recombinant)

1 Market Overview

1.1 Coagulation Factor IX Product Introduction

1.2 Global Coagulation Factor IX Market Size Forecast

1.2.1 Global Coagulation Factor IX Sales Value (2019-2030)

1.2.2 Global Coagulation Factor IX Sales Volume (2019-2030)

1.2.3 Global Coagulation Factor IX Sales Price (2019-2030)

1.3 Coagulation Factor IX Market Trends & Drivers

1.3.1 Coagulation Factor IX Industry Trends

1.3.2 Coagulation Factor IX Market Drivers & Opportunity

1.3.3 Coagulation Factor IX Market Challenges

1.3.4 Coagulation Factor IX Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Coagulation Factor IX Players Revenue Ranking (2023)

2.2 Global Coagulation Factor IX Revenue by Company (2019-2024)

2.3 Global Coagulation Factor IX Players Sales Volume Ranking (2023)

2.4 Global Coagulation Factor IX Sales Volume by Company Players (2019-2024)

2.5 Global Coagulation Factor IX Average Price by Company (2019-2024)

2.6 Key Manufacturers Coagulation Factor IX Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Coagulation Factor IX Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Coagulation Factor IX

2.9 Coagulation Factor IX Market Competitive Analysis

2.9.1 Coagulation Factor IX Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Coagulation Factor IX Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor IX as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Coagulation Factor IX (Plasma Derived)

3.1.2 Coagulation Factor IX (Recombinant)

3.2 Global Coagulation Factor IX Sales Value by Type

3.2.1 Global Coagulation Factor IX Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Coagulation Factor IX Sales Value, by Type (2019-2030)

3.2.3 Global Coagulation Factor IX Sales Value, by Type (%) (2019-2030)

3.3 Global Coagulation Factor IX Sales Volume by Type

3.3.1 Global Coagulation Factor IX Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Coagulation Factor IX Sales Volume, by Type (2019-2030)

3.3.3 Global Coagulation Factor IX Sales Volume, by Type (%) (2019-2030)

3.4 Global Coagulation Factor IX Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Adult

4.1.2 Kids

4.2 Global Coagulation Factor IX Sales Value by Application

4.2.1 Global Coagulation Factor IX Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Coagulation Factor IX Sales Value, by Application (2019-2030)

4.2.3 Global Coagulation Factor IX Sales Value, by Application (%) (2019-2030)

4.3 Global Coagulation Factor IX Sales Volume by Application

4.3.1 Global Coagulation Factor IX Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Coagulation Factor IX Sales Volume, by Application (2019-2030)

4.3.3 Global Coagulation Factor IX Sales Volume, by Application (%) (2019-2030)

4.4 Global Coagulation Factor IX Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Coagulation Factor IX Sales Value by Region

5.1.1 Global Coagulation Factor IX Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Coagulation Factor IX Sales Value by Region (2019-2024)

5.1.3 Global Coagulation Factor IX Sales Value by Region (2025-2030)

5.1.4 Global Coagulation Factor IX Sales Value by Region (%), (2019-2030)

5.2 Global Coagulation Factor IX Sales Volume by Region

5.2.1 Global Coagulation Factor IX Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Coagulation Factor IX Sales Volume by Region (2019-2024)

5.2.3 Global Coagulation Factor IX Sales Volume by Region (2025-2030)

5.2.4 Global Coagulation Factor IX Sales Volume by Region (%), (2019-2030)

5.3 Global Coagulation Factor IX Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Coagulation Factor IX Sales Value, 2019-2030

5.4.2 North America Coagulation Factor IX Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Coagulation Factor IX Sales Value, 2019-2030

5.5.2 Europe Coagulation Factor IX Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Coagulation Factor IX Sales Value, 2019-2030

5.6.2 Asia Pacific Coagulation Factor IX Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Coagulation Factor IX Sales Value, 2019-2030

5.7.2 South America Coagulation Factor IX Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Coagulation Factor IX Sales Value, 2019-2030

5.8.2 Middle East & Africa Coagulation Factor IX Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Coagulation Factor IX Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Coagulation Factor IX Sales Value

6.2.1 Key Countries/Regions Coagulation Factor IX Sales Value, 2019-2030

6.2.2 Key Countries/Regions Coagulation Factor IX Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Coagulation Factor IX Sales Value, 2019-2030

6.3.2 United States Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Coagulation Factor IX Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Coagulation Factor IX Sales Value, 2019-2030

6.4.2 Europe Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Coagulation Factor IX Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Coagulation Factor IX Sales Value, 2019-2030

6.5.2 China Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

6.5.3 China Coagulation Factor IX Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Coagulation Factor IX Sales Value, 2019-2030

6.6.2 Japan Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Coagulation Factor IX Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Coagulation Factor IX Sales Value, 2019-2030

6.7.2 South Korea Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Coagulation Factor IX Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Coagulation Factor IX Sales Value, 2019-2030

6.8.2 Southeast Asia Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Coagulation Factor IX Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Coagulation Factor IX Sales Value, 2019-2030

6.9.2 India Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

6.9.3 India Coagulation Factor IX Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Company Information

7.1.2 Pfizer Introduction and Business Overview

7.1.3 Pfizer Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Pfizer Coagulation Factor IX Product Offerings

7.1.5 Pfizer Recent Development

7.2 CSL Behring

7.2.1 CSL Behring Company Information

7.2.2 CSL Behring Introduction and Business Overview

7.2.3 CSL Behring Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)

7.2.4 CSL Behring Coagulation Factor IX Product Offerings

7.2.5 CSL Behring Recent Development

7.3 Grifols

7.3.1 Grifols Company Information

7.3.2 Grifols Introduction and Business Overview

7.3.3 Grifols Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Grifols Coagulation Factor IX Product Offerings

7.3.5 Grifols Recent Development

7.4 Novo Nordisk

7.4.1 Novo Nordisk Company Information

7.4.2 Novo Nordisk Introduction and Business Overview

7.4.3 Novo Nordisk Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Novo Nordisk Coagulation Factor IX Product Offerings

7.4.5 Novo Nordisk Recent Development

7.5 Bioverativ

7.5.1 Bioverativ Company Information

7.5.2 Bioverativ Introduction and Business Overview

7.5.3 Bioverativ Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Bioverativ Coagulation Factor IX Product Offerings

7.5.5 Bioverativ Recent Development

7.6 Sanquin

7.6.1 Sanquin Company Information

7.6.2 Sanquin Introduction and Business Overview

7.6.3 Sanquin Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Sanquin Coagulation Factor IX Product Offerings

7.6.5 Sanquin Recent Development

7.7 Takeda

7.7.1 Takeda Company Information

7.7.2 Takeda Introduction and Business Overview

7.7.3 Takeda Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Takeda Coagulation Factor IX Product Offerings

7.7.5 Takeda Recent Development

7.8 Baxter

7.8.1 Baxter Company Information

7.8.2 Baxter Introduction and Business Overview

7.8.3 Baxter Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Baxter Coagulation Factor IX Product Offerings

7.8.5 Baxter Recent Development

7.9 Aptevo

7.9.1 Aptevo Company Information

7.9.2 Aptevo Introduction and Business Overview

7.9.3 Aptevo Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Aptevo Coagulation Factor IX Product Offerings

7.9.5 Aptevo Recent Development

8 Industry Chain Analysis

8.1 Coagulation Factor IX Industrial Chain

8.2 Coagulation Factor IX Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Coagulation Factor IX Sales Model

8.5.2 Sales Channel

8.5.3 Coagulation Factor IX Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Coagulation Factor IX Market Trends

Table 2. Coagulation Factor IX Market Drivers & Opportunity

Table 3. Coagulation Factor IX Market Challenges

Table 4. Coagulation Factor IX Market Restraints

Table 5. Global Coagulation Factor IX Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Coagulation Factor IX Revenue Market Share by Company (2019-2024)

Table 7. Global Coagulation Factor IX Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Coagulation Factor IX Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Coagulation Factor IX Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Coagulation Factor IX Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Coagulation Factor IX Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Coagulation Factor IX

Table 13. Global Coagulation Factor IX Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor IX as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Coagulation Factor IX Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Coagulation Factor IX Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Coagulation Factor IX Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Coagulation Factor IX Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Coagulation Factor IX Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Coagulation Factor IX Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Coagulation Factor IX Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Coagulation Factor IX Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Coagulation Factor IX Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Coagulation Factor IX Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Coagulation Factor IX Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Coagulation Factor IX Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Coagulation Factor IX Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Coagulation Factor IX Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Coagulation Factor IX Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Coagulation Factor IX Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Coagulation Factor IX Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Coagulation Factor IX Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Coagulation Factor IX Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Coagulation Factor IX Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Coagulation Factor IX Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Coagulation Factor IX Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Coagulation Factor IX Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Coagulation Factor IX Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Coagulation Factor IX Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Coagulation Factor IX Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Coagulation Factor IX Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Coagulation Factor IX Sales Value by Region (2019-2024) & (%)

Table 44. Global Coagulation Factor IX Sales Value by Region (2025-2030) & (%)

Table 45. Global Coagulation Factor IX Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Coagulation Factor IX Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Coagulation Factor IX Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Coagulation Factor IX Sales Volume by Region (2019-2024) & (%)

Table 49. Global Coagulation Factor IX Sales Volume by Region (2025-2030) & (%)

Table 50. Global Coagulation Factor IX Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Coagulation Factor IX Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Coagulation Factor IX Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Coagulation Factor IX Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Coagulation Factor IX Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Coagulation Factor IX Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Coagulation Factor IX Sales Volume, (2025-2030) & (K Units)

Table 57. Pfizer Company Information

Table 58. Pfizer Introduction and Business Overview

Table 59. Pfizer Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Pfizer Coagulation Factor IX Product Offerings

Table 61. Pfizer Recent Development

Table 62. CSL Behring Company Information

Table 63. CSL Behring Introduction and Business Overview

Table 64. CSL Behring Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. CSL Behring Coagulation Factor IX Product Offerings

Table 66. CSL Behring Recent Development

Table 67. Grifols Company Information

Table 68. Grifols Introduction and Business Overview

Table 69. Grifols Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Grifols Coagulation Factor IX Product Offerings

Table 71. Grifols Recent Development

Table 72. Novo Nordisk Company Information

Table 73. Novo Nordisk Introduction and Business Overview

Table 74. Novo Nordisk Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Novo Nordisk Coagulation Factor IX Product Offerings

Table 76. Novo Nordisk Recent Development

Table 77. Bioverativ Company Information

Table 78. Bioverativ Introduction and Business Overview

Table 79. Bioverativ Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Bioverativ Coagulation Factor IX Product Offerings

Table 81. Bioverativ Recent Development

Table 82. Sanquin Company Information

Table 83. Sanquin Introduction and Business Overview

Table 84. Sanquin Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Sanquin Coagulation Factor IX Product Offerings

Table 86. Sanquin Recent Development

Table 87. Takeda Company Information

Table 88. Takeda Introduction and Business Overview

Table 89. Takeda Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Takeda Coagulation Factor IX Product Offerings

Table 91. Takeda Recent Development

Table 92. Baxter Company Information

Table 93. Baxter Introduction and Business Overview

Table 94. Baxter Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Baxter Coagulation Factor IX Product Offerings

Table 96. Baxter Recent Development

Table 97. Aptevo Company Information

Table 98. Aptevo Introduction and Business Overview

Table 99. Aptevo Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Aptevo Coagulation Factor IX Product Offerings

Table 101. Aptevo Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Coagulation Factor IX Downstream Customers

Table 105. Coagulation Factor IX Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Coagulation Factor IX Product Picture

Figure 2. Global Coagulation Factor IX Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Coagulation Factor IX Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Coagulation Factor IX Sales Volume (2019-2030) & (K Units)

Figure 5. Global Coagulation Factor IX Sales Price (2019-2030) & (USD/Unit)

Figure 6. Coagulation Factor IX Report Years Considered

Figure 7. Global Coagulation Factor IX Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Coagulation Factor IX Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Coagulation Factor IX Revenue in 2023

Figure 10. Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Coagulation Factor IX (Plasma Derived) Picture

Figure 12. Coagulation Factor IX (Recombinant) Picture

Figure 13. Global Coagulation Factor IX Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Coagulation Factor IX Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Coagulation Factor IX Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Coagulation Factor IX Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Coagulation Factor IX Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Adult

Figure 19. Product Picture of Kids

Figure 20. Global Coagulation Factor IX Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Coagulation Factor IX Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Coagulation Factor IX Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Coagulation Factor IX Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Coagulation Factor IX Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Coagulation Factor IX Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Coagulation Factor IX Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Coagulation Factor IX Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Coagulation Factor IX Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Coagulation Factor IX Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Coagulation Factor IX Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Coagulation Factor IX Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Coagulation Factor IX Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Coagulation Factor IX Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Coagulation Factor IX Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Coagulation Factor IX Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Coagulation Factor IX Sales Volume (%), (2019-2030)

Figure 37. United States Coagulation Factor IX Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Coagulation Factor IX Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Coagulation Factor IX Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Coagulation Factor IX Sales Value by Application (%), 2023 VS 2030

Figure 43. China Coagulation Factor IX Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

Figure 45. China Coagulation Factor IX Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Coagulation Factor IX Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Coagulation Factor IX Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Coagulation Factor IX Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Coagulation Factor IX Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Coagulation Factor IX Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Coagulation Factor IX Sales Value by Application (%), 2023 VS 2030

Figure 55. India Coagulation Factor IX Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Coagulation Factor IX Sales Value by Type (%), 2023 VS 2030

Figure 57. India Coagulation Factor IX Sales Value by Application (%), 2023 VS 2030

Figure 58. Coagulation Factor IX Industrial Chain

Figure 59. Coagulation Factor IX Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4D7214

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Coagulation Factor IX - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-36J6919

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Clindamycin Phosphate Topical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-19S7015

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Doxercalciferol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-29V6890

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Coagulation Factor IX - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-36J6919

Coagulation Factor IX - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Coagulation Factor IX - Market Size

Coagulation Factor IX - Market

Report Scope

Scope of Coagulation Factor IX - Market Report

Chapter Outline

FAQ for this report

What is the Coagulation Factor IX - Market size in 2030?

Who are the main players in the Coagulation Factor IX - Market report?

What are the Application segmentation covered in the Coagulation Factor IX - Market report?

What are the Type segmentation covered in the Coagulation Factor IX - Market report?

FEATURED COMPANIES

RELATED REPORTS